Q1 2026 Cardinal Health Inc Earnings Call Transcript
Key Points
- Cardinal Health Inc (CAH) reported strong double-digit profit growth across all five operating segments, highlighting the company's robust performance.
- The pharmaceutical and specialty solutions segment experienced a 23% revenue increase, driven by brand and specialty pharmaceutical sales growth.
- The acquisition of Solaris Health is expected to accelerate specialty growth strategy and create long-term value for patients, providers, and shareholders.
- The company raised its full-year EPS guidance to a range of $9.65 to $9.85, reflecting confidence in continued strong performance.
- Cardinal Health Inc (CAH) generated $1.3 billion in adjusted free cash flow during the first quarter, demonstrating effective cash flow management.
- The distribution of COVID vaccines presented a slight year-over-year headwind in Q1, with expectations of a similar impact in Q2.
- Interest and other expenses increased by $43 million to $70 million due to financing costs related to acquisitions.
- The GMPD segment faces challenges with tariffs, which are anticipated to be near the high end of the $50 million to $75 million range.
- The company expects a step-up in tariff costs in the second quarter, impacting GMPD's profitability.
- Despite strong performance, the company acknowledges the dynamic legislative and regulatory environment, which could pose future challenges.
Hello and welcome to the first quarter fiscal year 2026 Cardinal Health Incorporated earnings conference call. My name is Sergei, and I'll be your coordinator for today's event.
(Operator Instructions) And now I'd like to hand the call over to Matt Sims, Vice President of investor relations. Please go ahead, sir.
Good morning and welcome to Cardinal Health's first quarter fiscal '26 earnings conference call and thank you for joining us. With me today are Cardinal Health CEO, Jason Haller; and our CFO, Aaron All. You can find this morning's earnings press release and investor presentation on the investor relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
